Sydney - Thursday - November 13: (RWE Aust Business News) - Progen's (ASX:PGL) strategic review has recommended a capital return of 50c a share, ($30.2m or 43pc of estimated cash reserves at February 2009). Shareholder approval will be required. Progen says the return will meet legitimate concerns raised by shareholders in the period since the cancellation of PI-88 while leaving it with sufficient funds to continue as a viable and significant biotechnology company.
PGL Price at posting:
65.0¢ Sentiment: LT Buy Disclosure: Held